baber/WOPTO huggingface dataset:
Patent AU-3150595-A (AU)
Title: Network communication unit using an adaptive router
Inventor: DUZETT ROBERT C
IPC: G06F15/177
Filed: 1995-07-28
Abstract: A parallel processor network comprised of a plurality of nodes, each node including a processor containing a number of I/O ports, and a local memory. A communication path is established through a node by comparing a target node address in a first address packet with a processor ID of the node. If node address is equal to the target node address a receive channel is allocated to the input port and a route ready command is sent over an output port paired with the input port. If the node address is not equal to the target node address, then a first unallocated output port is selected from a port vector and the address packet is forwarded to a next node over the selected output port.
Patent AU-3217599-A (AU)
Title: Methods for the diagnosis and treatment of lung cancer
Inventor: JEN JIN
IPC: C12Q1/68
Filed: 1999-03-30
Abstract: The present invention provides methods for aiding in the diagnoses of the neoplastic condition of a lung cell and methods of screening for a potential therapeutic agent for the reversal of the neoplastic condition.
Patent AU-3731285-A (AU)
Title: Fibre reinforced moulded plastics articles
Inventor: RADVAN BRONISLAW
IPC: B29B15/10
Filed: 1985-01-04
Abstract: A process for moulding articles of permeable sheet-like fibre-reinforced unconsolidated particulate plastics material which has been bonded together and which includes heating the material to a moulding temperature by the passage of hot temperature air through the sheet and then subjecting it to a moulding process.
Patent AU-4031489-A (AU)
Title: A circuit for starting and operating a gas discharge lamp
Inventor: JENSEN KAJ
IPC: H05B41/392
Filed: 1989-02-17
Abstract: PCT No. PCT/NO89/00036 Sec. 371 Date Aug. 16, 1990 Sec. 102(e) Date Aug. 16, 1990 PCT Filed Feb. 17, 1989 PCT Pub. No. WO89/07877 PCT Pub. Date Aug. 24, 1989.A circuit for starting and operating a gas discharge lamp (11) comprises: a DC power supply (73), which generates a DC power supply voltage; a high voltage generator (16, 18), which generates a high DC starting voltage from the DC power supply voltage and supplies the high DC starting voltage to the gas discharge lamp (11) so as to bring about a current flow therethrough; and inductor (15), which is connected in a closed loop circuit together withthe gas discharge lamp (11); a sensor (48), which is connected to the closed loop circuit for detecting the transmission of power therein; and a power switching (59, 60), which is switchable between a conducting state in which power is induced into the inductor (15) and a non-conducting state in which no power is induced into the inductor (15), and which is controlled by the sensor (48).
Patent AU-4045893-A (AU)
Title: Flying die machine
Inventor: SCHACH HERBERT U
IPC: B23D21/00
Filed: 1993-04-01
Abstract: A flying die apparatus including a reciprocally movable carriage mounting a plurality of die heads capable of performing sequential or concurrent operations on a strip stock segment aligned and moving with the carriage. The die support heads include a rotatable coupling which provides a common source of pressurized fluid for die actuators forming part of the head while enabling the die elements to be rotated with respect to the processing line. Rotatable nut assemblies engageable with elongated ball screw shafts interconnect the heads to maintain a rigid spacing between the heads while providing a means for adjusting the relative position of the heads with respect to each other. A gimbal mounting is also provided to enable the die support heads to be angled with respect to the processing line to perform angled cuts, etc.
Patent AU-4077496-A (AU)
Title: Solderless electrolytically severable joint for detachable devices placed within mammalian body
Inventor: GIA SON
IPC: A61F2/06
Filed: 1996-01-02
Abstract: This is a solderless sacrificial link between a detachable member which is placed at and is intended to remain at a desired site within the mammalian body and the core wire used to introduce the detachable member. The detachable member device may be one use to create emboli in the vascular system or may be of any other type deliverable into the human body and detached into an ionic aqueous environment, either for later removal or permanent placement. <IMAGE>
Patent AU-4165289-A (AU)
Title: Pipecolic acid-containing peptolides, their preparation and pharmaceutical compositions containing them
Inventor: DREYFUSS MICHAEL MORRIS
IPC: C07K7/64
Filed: 1989-09-22
Abstract: Pipecolic acid-containing peptolides wherein the peptidic backbone is of at least 9  alpha -amino acid residues joined together by peptide bonds, particularly the compounds of formula I <CHEM>  wherein the substituents have various significances, are disclosed. They can be prepared by isolation or derivation from an appropriate microorganism strain such as S 42508/F (NRRL 15761). They have interesting pharmacological, e.g. antifungal, chemotherapeutic drug resistance reversing and to some extent immunosuppressant and antiinflammatory properties.
Patent AU-4456897-A (AU)
Title: Mirror-symmetrical selection and evolution of nucleic acids
Inventor: FURSTE JENS PETER
IPC: A23L29/00
Filed: 1997-08-29
Abstract: A method is disclosed for identifying and producing L-nucleic acids which interact with a target molecule having a natural configuration, as well as the L-nucleic acids produced by this method. Also disclosed is the use of D-nucleic acids which bind to the optical antipode of the target molecule as a matrix for producing L-nucleic acids with an identical sequence, and pharmaceutical compositions and kits which contain the disclosed L-nucleic acids.
Patent AU-4579299-A (AU)
Title: Use of bi-specific antibodies for pre-targeting diagnosis and therapy
Inventor: HANSEN HANS J
IPC: A61K47/48
Filed: 1999-06-22
Abstract: The present invention relates to a bi-specific antibody or antibody fragment having at least one arm that specifically binds a targeted tissue and at least one other arm that specifically binds a targetable conjugate. The targetable conjugate comprises a carrier portion which comprises or bears at least one epitope recognizable by at least one arm of said bi-specific antibody or antibody fragment. The targetable conjugate further comprises one or more therapeutic or diagnostic agents or enzymes. The invention provides constructs and methods for producing the bi-specific antibodies or antibody fragments, as well as methods for using them.
Patent AU-4742500-A (AU)
Title: Immunoadsorber for use in sepsis therapy
Inventor: HEINRICH HANS-WERNER
IPC: A61K35/16
Filed: 2000-03-23
Abstract: The invention relates to immunoadsorbers for use in sepsis therapy, in particular for removal of complement factors and lipopolysaccharides (LPS) and, if need be, further sepsis mediators such as TNF and interleukins from body fluids, methods for their production and their use.
Patent AU-4792690-A (AU)
Title: New process for separating optical isomers of 1,4-dihydropyridine derivatives
Inventor: PEGLION JEAN-LOUIS
IPC: C07D405/12
Filed: 1990-01-12
Abstract: New process for separating optical isomers of the compounds of general formula I: <IMAGE>  in which:   - Ar denotes a phenyl radical optionally containing one to five identical or different substituents, each denoting a halogen atom, an alkoxy radical containing from 1 to 4 carbon atoms, an alkylthio radical containing from 1 to 4 carbon atoms, a trihalomethyl radical or a methylenedioxy radical, - each of Y, Z, Y1 and Z1, which are identical or different, denotes a hydrogen atom, a linear or branched lower alkyl radical containing from 1 to 4 carbon atoms, a cyclopropyl radical, a dicyclopropylmethyl radical, a 2,2-dicyclopropylethyl radical, a 2,2-dicyclopropylethylene radical, a 3,3-dicyclopropylpropyl radical, a 3,3-dicyclopropyl-1-propylene radical, a linear or branched alkylene radical containing from 2 to 5 carbon atoms or a phenyl radical optionally substituted by a nitro radical, and   - n is equal to 1, 2 or 3.
Patent AU-4832779-A (AU)
Title: 2-(2-alkoxyethyl)-2:-hydroxy-6,7-benzomorphanes
Inventor: MERZ HERBERT
IPC: A61K31/445
Filed: 1979-06-22
Abstract: Compounds of the formula   <IMAGE>   wherein R1 is methyl, ethyl or propyl; R2 is hydrogen, methyl or ethyl; and R3 is    <IMAGE> (a) <IMAGE> (b)  or   <IMAGE> (c)  where R4 is hydrogen or methyl, R5 is methyl, ethyl or propyl, and n is 1 or 2, and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds as well as the salts are useful as analgesics.
Patent AU-5045690-A (AU)
Title: Composition and method for treating benign prostatic hypertrophy
Inventor: GOKCEN MUHARREM
IPC: A61K38/54
Filed: 1990-01-19
Abstract: The invention provides a composition and method for treating benign prostatic hypertrophy in mammals so as to cause the dissolution and regression of hypertrophied prostatic tissue and thereby provide relief from the obstructive symptoms associated with the disease. The present composition preferably comprises a sterile pyrogen-free solution of the hydrolytic enzymes collagenase and hyaluronidase, a nonionic surfactant, and an antibiotic; all provided, in a pharmaceutically acceptable, buffered, isotonic, aqueous carrier. The present method preferably comprises the direct intraprostatic injection of a safe and therapeutically effective dose of the composition via the transurethral route of administration.
Patent AU-5148885-A (AU)
Title: Process for the preparation of monochloroacetic acid from glycolic acid
Inventor: CORREIA YVES
IPC: C07C51/363
Filed: 1985-12-19
Abstract: 1. Process for the preparation of monochloroacetic acid by hydrochlorination of glycolic acid, this process being characterized in that the reaction is carried out in the presence of a catalyst consisting of a Lewis acid other than a hydracid.
Patent AU-5161599-A (AU)
Title: Novel urokinase inhibitors
Inventor: WILHELM OLAF
IPC: A61K31/495
Filed: 1999-07-20
Abstract: Sulfonyl-substituted 3-amidino-phenylalanine derivatives (I) are used for the diagnosis, therapy or prevention of diseases associated with urokinase (UK) or UK receptors. Use of amidines of formula (I) (as the racemate or the D- or L-isomer) or their salts is claimed for the preparation of a composition for the diagnosis, therapy or prevention of diseases associated with UK or UK receptors. R1 = (i) OH, OR4 or NR5R6; (ii) 2- or 3-(COR7)-pyrrolidino, 2-, 3- or 4-(COR7)-piperidino (all optionally further substituted) or optionally 2-, 3- or 4-substituted piperidyl (all optionally having a fused aromatic or cycloaliphatic ring in the 2,3- or 3,4-position relative to the heteroatom); (iii) 4-(R8)-piperazino, COX, CONR'R'', CSNR'R'', SO2Y or (CH2)mX' (where the (CH2)m chain is optionally branched); or (iv) aralkyl, 5-8C cycloaliphatic ring, heteroaryl or heterocycloaliphatic group (all optionally ring substituted); R4 = optionally substituted 1-8C alkyl, 3-8C cycloalkyl or aralkyl; R5, R6 = arbitrary residues; R7 = OH, OR4, NR5R6 or 4-(R8)-piperazino; R8 = 1-6C alkyl, aryl, phenoxycarbonyl or benzyloxycarbonyl (all optionally substituted); or optionally unsaturated 1-6C alkoxy; X = H or (all optionally substituted) alkyl, aryl, heteroaryl or cycloalkyl; R', R'' = H or 1-4C alkyl; or R'' may also be aryl if R' = H; or NR'R'' = 5-7 membered heterocycloaliphatic ring, optionally containing a further heteroatom; Y = 1-8C alkyl, aryl, heteroaryl, aryloxy or heteroaryloxy (all optionally substituted); or NH2 or mono- or di-(1-3C alkyl)-amino; m = 1-8; X' = OH (optionally etherified by 1-4C alkyl, aralkyl, aryl or 1-4C hydroxyalkyl; or acylated by 2-7C alkanoyl), halo or tri-(1-3C alkyl)-amino (where the N may be part of a 5-7 membered ring optionally containing a further S heteroatom); R2 = optionally substituted phenyl; R3 = H or 1-4C alkyl; n = 0 or 1. Independent claims are included for: (1) N alpha -(2,4,6-triisopropyl-phenylsulfonyl)-3-amidino-D,L-phenylalanine-4-eth oxycarbonyl-piperazide (Ia), the corresponding L-enantiomer and their salts; (2) the use of compounds of formula R2-Z (II) or their salts for the preparation of a composition for targeting lymph cells; (3) a method for inhibiting UK in living organisms (especially humans) by adminstration of (I); and (4) a method for targeting lymph tissue in living organisms by administration of (II). Z = arbitrary group.
Patent AU-5302196-A (AU)
Title: Vascular endothelial growth factor-b
Inventor: ERIKSSON ULF
IPC: C12P21/08
Filed: 1996-03-01
Abstract: VEGF-B polypeptides from the PDGF family of growth factors having the property of promoting mitosis and proliferation of vascular endothelial cells, DNA sequences encoding these polypeptides, pharmaceutical compositions containing them and antibodies which react with them. The VEGF-B polypeptides are useful in stimulating angiogenesis as well as in diagnostic applications.
Patent AU-5310290-A (AU)
Title: Ultravoilet ray measuring apparatus
Inventor: HAYASHI MUTSUMI
IPC: G01J1/42
Filed: 1990-04-10
Abstract: An ultraviolet ray measuring apparatus is provided which comprises first and second photodiodes (101, 201) having substantially the same spectral sensitivity at least in an ultraviolet band, and a first optical filter (202, 204, 206) arranged in front of a light-receiving face (201) of the second photodiode, for shielding only light of at least a part of the ultraviolet band, and measures the light intensity and its accumulated value in accordance with the difference between electric signals output from the first and second photodiodes. According to the ultraviolet ray measuring apparatus of the invention, a second optical filter (30, 30A), which has a main transmitting band in the ultraviolet band and a sub-transmitting band in the visible light range, is arranged in front of the light-receiving faces of the first and second photodiode. A multi-step bar graph display device (4b) displays indexes, such as an MED multiple value and an SPF value, which represent the measured light intensity and accumulated value in association with a reference MED value, so that this apparatus can suitably serve as a sunburn monitor.
Patent AU-5359196-A (AU)
Title: User independent, real-time speech recognition system and method
Inventor: HANSEN C HAL
IPC: G10L15/20
Filed: 1996-03-11
Abstract: A system and method for identifying the phoneme sound types that are contained within an audio speech signal is disclosed. The system includes a microphone (12) and associated conditioning circuitry (14), for receiving an audio speech signal and converting it to a representative electrical signal. The electrical signal is then sampled and converted to a digital audio signal with a digital-to-analog converter (34). The digital audio signal is input to a programmable digital sound processor (18), which digitally processes the sound so as to extract various time domain and frequency domain sound characteristics. These characteristics are input to a programmable host sound processor (20) which compares the sound characteristics to standard sound data. Based on this comparison, the host sound processor (20) identifies the specific phoneme sounds that are contained within the audio speech signal. The programmable host sound processor (20) further includes linguistic processing program methods to convert the phoneme sounds into English words or other natural language words. These words are input to a host processor (22), which then utilizes the words as either data or commands.
Patent AU-5367894-A (AU)
Title: Sport boot liner and method for making same
Inventor: LANG HERBERT
IPC: A43B19/00
Filed: 1993-11-04
Abstract: PCT No. PCT/CA93/00458 Sec. 371 Date May 4, 1995 Sec. 102(e) Date May 4, 1995 PCT Filed Nov. 4, 1993 PCT Pub. No. WO94/09663 PCT Pub. Date May 11, 1994A liner for a sport boot shell and a method for making a custom fitted liner for a sport boot, are disclosed. The liner is designed to be worn inside a boot shell. In a preferred embodiment the liner includes inner and outer of flaps which wrap in opposite directions across a wearer's shin and forms a compound curve in a region in front of the wearer's ankle. The liner including flaps may be made from a single piece of thermoplastic foam material of uniform thickness. The design of the liner prevents the cuff of the liner from loosening around the wearer's shin and calf when the wearer's leg is flexed forward at the ankle. The shell can therefore be worn more loosely than is necessary with a boot liner of conventional design. The liner may be made by making an unfitted liner from a sheet of thermoformable material. The unfitted liner has a forwardly facing opening and wings extending forwardly on either side of opening. The unfitted liner is then heated to above the thermoforming temperature of the material and simultaneously fitted to the shell and the wearer's foot and leg by the steps of: placing the wearer's foot into the unfitted liner; forming flaps by wrapping the wings across the wearer's shin; holding the unfitted liner in place with an elastic stocking; inserting the wearer's foot, the unfitted liner and the elastic stocking into the shell and allowing the unfitted liner to cool.
Patent AU-5547290-A (AU)
Title: Chymopapain and its preparation, use and pharmaceutical compositions comprising same
Inventor: BARRETT ALAN JOHN
IPC: C07K17/10
Filed: 1990-04-27
Abstract: A pharmaceutical composition comprising purified chymopapain and a reducing agent is presented. The purified chymopapain in this composition has a specific activity against 1 mM of N- alpha -benzoyl-DL-arginine p-nitroanilide at 40 DEG  C. and pH 6.8 of between 3,000 and 4,500 units per mg, and contains less than 0.2% each of papaya proteinase III (PPIII), papain, and papaya proteinase IV (PPIV).
Patent AU-5710180-A (AU)
Title: Electronic organ chord former
Inventor: BERKERS WILHELMUS ANTONIUS JOS
IPC: G10H1/38
Filed: 1980-04-02
Abstract: A chord performing apparatus for an electronic organ with a chord-former, comprises control inputs for control signals defining the chord tone, and control inputs for control signals defining the chord type and control units which can be preset in accordance with a pattern of chord tones and chord types to be played and outputs which are scanned and controlled in the rhythm of the melody for performing the same function as the switch elements, connected with the control inputs of the chord-former.
Patent AU-5739399-A (AU)
Title: Packaging material with a foamed polyolefin layer
Inventor: REINERS ULRICH
IPC: B32B5/18
Filed: 1999-08-24
Abstract: The invention relates to a multilayer film comprising the following sequence of layers: A) a basis layer of polyolefin foam, B) a layer based on at least one of the polyolefins of the foam layer A), C) optionally a tie layer based on a polyolefin, D) optionally an adhesive layer, E) optionally a gas- and/or flavortight barrier layer, F) an adhesive layer, G) an optionally sealable and/or peelable surface layer, whereby the total thickness of layers A) and B) ranges from 0.5 to 2 mm and the thickness of layer B) ranges from 1/6 to ½ of the thickness of layer A).
Patent AU-5758396-A (AU)
Title: Sealing ring
Inventor: FEISTEL NORBERT
IPC: F16J9/16
Filed: 1996-06-04
Abstract: The invention relates to a sealing ring for sealing a piston rod of a piston compressor. The sealing ring comprises three segments, wherein the segments have portions extending in the circumferential direction of the sealing ring, which form an overlapping joint. The overlapping joint brings about an excellent sealing effect in the axial direction.
Patent AU-6081796-A (AU)
Title: Improved capsule chemistry analytical methods employing dioxetane chemiluminescence
Inventor: ADOLFSEN ROBERT H
IPC: C12Q1/42
Filed: 1996-07-30
Abstract: Improved assay methods utilizing stable, enzymatically triggered chemiluminescent 1,2-dioxetanes with improved water solubility are provided. Assays are performed by a capsule chemistry analytical assay method wherein fluid capsules comprising discrete aqueous segments containing either a chemiluminescent dioxetane reagent or an activating agent separated by an oil-based isolating fluid are flowed through a conduit, and subsequently reacted to produce light. The improvement comprises using a dioxetane substituted with two or more water-solubilizing groups disposed on the dioxetane structure to provide the chemiluminescence. Compositions comprising such a dioxetane, a non-polymeric surfactant enhancer and optionally a fluorescer, provide enhanced chemiluminescence and eliminate the problem of reagent carryover when used in assays performed on capsule chemistry analytical systems. <IMAGE>
Patent AU-6113496-A (AU)
Title: Multiple zone limiting orifice drying of cellulosic fibrous structures, apparatus therefor, and cellulosic fibrous structures produced thereby
Inventor: ENSIGN DONALD EUGENE
IPC: D21F5/14
Filed: 1996-06-03
Abstract: A limiting orifice through-air-drying apparatus for papermaking or other absorbent embryonic webs. The apparatus has a first zone (41) and a second zone (42). The first (41) zone is maintained at a differential pressure less than the breakthrough pressure, while the second zone (42) is maintained at a differential pressure greater than the breakthrough pressure. The residence time of the embryonic web to be dried with the apparatus is maintained at preferably less than 35 milliseconds on the first zone. Using the dual zone system described above, the overall energy required to run the apparatus can be reduced.
Patent AU-6263001-A (AU)
Title: Finger-guided suture device
Inventor: LEVY GIL
IPC: A61B17/04
Filed: 2001-05-24
Abstract: A finger-guided suture device (20) is disclosed. The device includes a thimble-like element (22) to surround a portion of the finger and an ejectable substantially semi-circular surgical needle (24) for collecting retaining and guiding a surgical suture via a distal portion of the needle upon contact. Also included is a mechanism (30) for ejecting the needle from, and withdrawing the needle into, the thimble-like element, so as to place a suture. Also disclosed arc surgical methods employing the device.
Patent AU-6320480-A (AU)
Title: Piperidine derivatives of 4,5-dialkyl-3-hydroxy-pyrrole-2- carboxylic acid esters
Inventor: FRICKEL F F
IPC: C07D207/34
Filed: 1980-10-13
Abstract: Substituted piperidinoalkyl ethers of 4,5-dialkyl-3-hydroxy-pyrrole-2-carboxylic acid esters and their physiologically tolerated addition salts with acids, processes for their preparation and pharmaceutical formulations which contain these compounds and are useful in the treatment of cardiac arrhythmias.
Patent AU-6594794-A (AU)
Title: Isolated DNA sequence which can serve as terminator region in a chimeric gene capable of being used for the transformation of plants
Inventor: ATANASSOVA ROSSITZA
IPC: C12N15/29
Filed: 1994-06-24
Abstract: 1) Chimeric gene for plant transformation. 2) It comprises at least, in the direction of transcription, a promoter region, a transgene and a termination region, characterised in that the termination region consists of at least one termination region of a plant histone gene which permits the expression of the protein in the regions of rapid growth. 3) Production of transgenic plants.
Patent AU-6610400-A (AU)
Title: Sequence determination of nucleic acids using electronic detection
Inventor: UMEK ROBERT M
IPC: C12Q1/68
Filed: 2000-07-26
Abstract: The present invention is directed to methods and compositions for the use of self-assembled monolayers to electronically detect nucleic acids, particularly alterations such as nucleotide substitutions (mismatches) and single nucleotide polymorphisms (SNPs).
Patent AU-6752494-A (AU)
Title: Gas oil composition
Inventor: GIAVAZZI FULVIO
IPC: C10L1/02
Filed: 1994-07-15
Abstract: A gas oil composition for motor vehicles, with a sulfur content lower than 0.2% by weight and with a content of aromatic hydrocarbons lower than about 30% by weight, contains, as a lubricity improver agent, an amount of from 100 to 10.000 ppm (parts per million parts by weight) of lower (C1-C5) alkyl esters of a mixture of saturated and unsaturated C12-C22 fatty acids, derived from vegetable oleaginous seeds.